VRTX
$VRTX
Vertex Pharmaceuticals
Biotech leader in cystic fibrosis treatments and pain therapies.
HealthcareSubscribers
1
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
VRTX: Vertex Outlook and Valuation
Vertex ($VRTX) trades around $515 as of Friday, September 11, with a mean analyst target near $569, implying roughly 10% upside. This report examines valuation, pipeline positioning, and key risks.
Sep 13, 2026